A trade under pressure at the rejection cluster

CRISPR Therapeutics is at week 9 of a buy signal that has struggled to gain traction: the trade is down 6.7% from entry and the confirmation week closed bearish. The model has issued an early-exit signal. The structural picture is not yet broken, but discipline calls for caution: the dynamic stop is nearly at entry, and the next model window falls at week 10.